Global Biopharmaceutical Contract Manufacturing Market Research Report 2023

Report ID: 1977817 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Growth Factors
        1.2.3 Interferons
        1.2.4 Monoclonal Antibodies
        1.2.5 Recombinant Hormones
        1.2.6 Vaccines
        1.2.7 Insulin
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Autoimmune Diseases
        1.3.3 Oncology
        1.3.4 Metabolic Diseases
        1.3.5 Ophthalmology
        1.3.6 Cardiovascular Diseases
        1.3.7 Infectious Diseases
        1.3.8 Neurology
        1.3.9 Respiratory Disorders
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2017-2028)
    2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region
        2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2017-2022)
        2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028)
    2.3 Biopharmaceutical Contract Manufacturing Market Dynamics
        2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends
        2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
        2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
        2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
        3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2017-2022)
        3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2017-2022)
    3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
    3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
        3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2021
    3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
    3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
    3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
    4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2017-2022)
    4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
    5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2017-2022)
    5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
    6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
    6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
    7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
    7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
    8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
    9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
    9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
    10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Lonza Group
        11.1.1 Lonza Group Company Detail
        11.1.2 Lonza Group Business Overview
        11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
        11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.1.5 Lonza Group Recent Development
    11.2 Baxter Biopharma Solutions
        11.2.1 Baxter Biopharma Solutions Company Detail
        11.2.2 Baxter Biopharma Solutions Business Overview
        11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
        11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.2.5 Baxter Biopharma Solutions Recent Development
    11.3 Samsung
        11.3.1 Samsung Company Detail
        11.3.2 Samsung Business Overview
        11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
        11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.3.5 Samsung Recent Development
    11.4 Fujifilm Diosynth Biotechnologies
        11.4.1 Fujifilm Diosynth Biotechnologies Company Detail
        11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
        11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
        11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
        11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 Patheon
        11.6.1 Patheon Company Detail
        11.6.2 Patheon Business Overview
        11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
        11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.6.5 Patheon Recent Development
    11.7 Rentschler Biotechnologie
        11.7.1 Rentschler Biotechnologie Company Detail
        11.7.2 Rentschler Biotechnologie Business Overview
        11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
        11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.7.5 Rentschler Biotechnologie Recent Development
    11.8 Biomeva
        11.8.1 Biomeva Company Detail
        11.8.2 Biomeva Business Overview
        11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
        11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.8.5 Biomeva Recent Development
    11.9 Probiogen
        11.9.1 Probiogen Company Detail
        11.9.2 Probiogen Business Overview
        11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
        11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.9.5 Probiogen Recent Development
    11.10 Cytovance Biologics
        11.10.1 Cytovance Biologics Company Detail
        11.10.2 Cytovance Biologics Business Overview
        11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
        11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.10.5 Cytovance Biologics Recent Development
    11.11 KBI Biopharma
        11.11.1 KBI Biopharma Company Detail
        11.11.2 KBI Biopharma Business Overview
        11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
        11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.11.5 KBI Biopharma Recent Development
    11.12 WuXi Biologics
        11.12.1 WuXi Biologics Company Detail
        11.12.2 WuXi Biologics Business Overview
        11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
        11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.12.5 WuXi Biologics Recent Development
    11.13 Abzena
        11.13.1 Abzena Company Detail
        11.13.2 Abzena Business Overview
        11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
        11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
        11.13.5 Abzena Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Growth Factors
    Table 3. Key Players of Interferons
    Table 4. Key Players of Monoclonal Antibodies
    Table 5. Key Players of Recombinant Hormones
    Table 6. Key Players of Vaccines
    Table 7. Key Players of Insulin
    Table 8. Key Players of Others
    Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2022)
    Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2023-2028)
    Table 15. Biopharmaceutical Contract Manufacturing Market Trends
    Table 16. Biopharmaceutical Contract Manufacturing Market Drivers
    Table 17. Biopharmaceutical Contract Manufacturing Market Challenges
    Table 18. Biopharmaceutical Contract Manufacturing Market Restraints
    Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2017-2022)
    Table 21. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
    Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
    Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2017-2022)
    Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2023-2028)
    Table 32. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2017-2022)
    Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2023-2028)
    Table 36. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Lonza Group Company Detail
    Table 47. Lonza Group Business Overview
    Table 48. Lonza Group Biopharmaceutical Contract Manufacturing Product
    Table 49. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 50. Lonza Group Recent Development
    Table 51. Baxter Biopharma Solutions Company Detail
    Table 52. Baxter Biopharma Solutions Business Overview
    Table 53. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product
    Table 54. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 55. Baxter Biopharma Solutions Recent Development
    Table 56. Samsung Company Detail
    Table 57. Samsung Business Overview
    Table 58. Samsung Biopharmaceutical Contract Manufacturing Product
    Table 59. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 60. Samsung Recent Development
    Table 61. Fujifilm Diosynth Biotechnologies Company Detail
    Table 62. Fujifilm Diosynth Biotechnologies Business Overview
    Table 63. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product
    Table 64. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 65. Fujifilm Diosynth Biotechnologies Recent Development
    Table 66. Boehringer Ingelheim Company Detail
    Table 67. Boehringer Ingelheim Business Overview
    Table 68. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product
    Table 69. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 70. Boehringer Ingelheim Recent Development
    Table 71. Patheon Company Detail
    Table 72. Patheon Business Overview
    Table 73. Patheon Biopharmaceutical Contract Manufacturing Product
    Table 74. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 75. Patheon Recent Development
    Table 76. Rentschler Biotechnologie Company Detail
    Table 77. Rentschler Biotechnologie Business Overview
    Table 78. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product
    Table 79. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 80. Rentschler Biotechnologie Recent Development
    Table 81. Biomeva Company Detail
    Table 82. Biomeva Business Overview
    Table 83. Biomeva Biopharmaceutical Contract Manufacturing Product
    Table 84. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 85. Biomeva Recent Development
    Table 86. Probiogen Company Detail
    Table 87. Probiogen Business Overview
    Table 88. Probiogen Biopharmaceutical Contract Manufacturing Product
    Table 89. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 90. Probiogen Recent Development
    Table 91. Cytovance Biologics Company Detail
    Table 92. Cytovance Biologics Business Overview
    Table 93. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product
    Table 94. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 95. Cytovance Biologics Recent Development
    Table 96. KBI Biopharma Company Detail
    Table 97. KBI Biopharma Business Overview
    Table 98. KBI Biopharma Biopharmaceutical Contract ManufacturingProduct
    Table 99. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 100. KBI Biopharma Recent Development
    Table 101. WuXi Biologics Company Detail
    Table 102. WuXi Biologics Business Overview
    Table 103. WuXi Biologics Biopharmaceutical Contract ManufacturingProduct
    Table 104. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 105. WuXi Biologics Recent Development
    Table 106. Abzena Company Detail
    Table 107. Abzena Business Overview
    Table 108. Abzena Biopharmaceutical Contract ManufacturingProduct
    Table 109. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
    Table 110. Abzena Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2021 VS 2028
    Figure 2. Growth Factors Features
    Figure 3. Interferons Features
    Figure 4. Monoclonal Antibodies Features
    Figure 5. Recombinant Hormones Features
    Figure 6. Vaccines Features
    Figure 7. Insulin Features
    Figure 8. Others Features
    Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application in 2021 & 2028
    Figure 10. Autoimmune Diseases Case Studies
    Figure 11. Oncology Case Studies
    Figure 12. Metabolic Diseases Case Studies
    Figure 13. Ophthalmology Case Studies
    Figure 14. Cardiovascular Diseases Case Studies
    Figure 15. Infectious Diseases Case Studies
    Figure 16. Neurology Case Studies
    Figure 17. Respiratory Disorders Case Studies
    Figure 18. Others Case Studies
    Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
    Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 21. Global Biopharmaceutical Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Region: 2021 VS 2028
    Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2021
    Figure 24. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
    Figure 25. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2021
    Figure 26. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
    Figure 28. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
    Figure 32. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Nordic Countries Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2028)
    Figure 40. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Latin America Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
    Figure 48. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Country (2017-2028)
    Figure 52. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 55. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 56. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 57. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 58. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 59. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 60. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 61. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 62. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 63. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 64. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 65. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 66. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Cytovance Biologics
KBI Biopharma
WuXi Biologics
Abzena
Frequently Asked Questions
Biopharmaceutical Contract Manufacturing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceutical Contract Manufacturing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceutical Contract Manufacturing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bio-plastics

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Biopsy Device

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More